Related Experiment Video
Updated: Jul 19, 2026
08:40
Surgical Technique of the 3-Dimensional-printed Personalized Hip Implant for the Treatment of Canine Hip Dysplasia
Published on: April 19, 2024
Tramadol today
1Department of Anesthesiology, University of Stellenbosch, Tygerberg, South Africa. pjlr@maties.sun.ac.za
Current Opinion in Anaesthesiology
|October 4, 2006
Summary
Tramadol offers moderate pain relief with fewer risks of respiratory depression, tolerance, and dependence compared to traditional opioids. This review examines its evidence-based role in modern pain management, particularly in postoperative settings.
Area of Science:
- Pharmacology
- Pain Management
- Anesthesiology
Background:
- Tramadol is a unique analgesic with multimodal action.
- It presents a lower risk profile for respiratory depression, tolerance, and dependence than pure opioid agonists.
- Despite potential side effects, its clinical utility is established.
Purpose of the Study:
- To provide an evidence-based review of tramadol's role in contemporary medical practice.
- To highlight tramadol's efficacy as an adjunct analgesic.
- To discuss its potential benefits in specific surgical contexts.
Main Methods:
- Literature review of existing studies on tramadol.
- Analysis of clinical evidence regarding its efficacy and safety.
- Evaluation of tramadol's use in various pain management scenarios.
Main Results:
- Tramadol provides moderate, dose-related pain relief.
- It is effective as an adjunct to NSAIDs for moderate postoperative pain and shivering.
- Potential advantages exist in pediatric, day-case surgery, and local anesthesia techniques.
Conclusions:
- Tramadol is a valuable option for moderate pain management.
- Its distinct pharmacological profile offers benefits over traditional opioids in certain situations.
- Further evidence supports its role as an adjunct in diverse clinical settings.
Related Concept Videos
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
01:20Opioid Analgesics: Morphine and Other Natural Cogeners
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
01:17Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
01:23Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
01:17Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...